Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-B7 (PCDHGB7) is a neural cadherin-like cell adhesion protein encoded by the PCDHGB7 gene, located within the protocadherin gamma gene cluster on chromosome 5[1][2]. It is part of the gamma subfamily B cluster and likely plays a critical role in the establishment and maintenance of neuron-specific cell–cell connections in the brain, contributing to neural circuit assembly and synaptic specificity[1][2]. It has multiple extracellular cadherin domains and a transmembrane domain, with a constant cytoplasmic region, and is mainly expressed in neural tissues[5]. In cancer, PCDHGB7 is frequently hypermethylated and downregulated, functioning as a tumor suppressor by inducing cell cycle arrest and apoptosis. The hypermethylation status of PCDHGB7 is a robust biomarker for the early, minimally invasive detection of several cancers, particularly endometrial cancer, outperforming conventional markers such as serum CA125[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-B7 (PCDHGB7).